...
首页> 外文期刊>Advances in Rheumatology >Durometry as an alternative tool to the modified Rodnan’s skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study
【24h】

Durometry as an alternative tool to the modified Rodnan’s skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study

机译:Durometry作为改良Rodnan的皮肤分数的替代工具,在弥漫性全身硬化症患者的评估中:横截面研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The reproducibility and reliability of the modified Rodnan’s Skin Score (mRSS) are debated due to investigator-related subjectivity. Here, we evaluate if durometry correlates with mRSS in patients with diffuse systemic sclerosis (SSc). This cross-sectional study was conducted from December 2018 to June 2019, including 58 diffuse SSc patients. Two certified researchers, blind to each other’s scores, performed the mRSS, followed by durometry at 17 predefined skin sites. For durometry and mRSS, individual scores per skin site were registered. Durometry and mRSS results measured by each researcher, as well as scores from different researchers, were compared. Skin thickness measurements from forearm skin biopsies were available in a subset of the patients, for comparisons. Statistical analyses included Cohen’s Kappa Coefficient, Intraclass Correlation Coefficient, Kendall’s Coefficient and Spearman’s test. Mean (standard deviation, SD) patient age was 44.8 (12.9) years, and 88% were female. Inter-rater agreement varied from 0.88 to 0.99 (Intraclass correlation coefficient) for durometry, and 0.54 to 0.79 (Cohen’s Kappa coefficient) for mRSS, according to the specific evaluated sites. When data were compared with skin thickness assessed in forearm biopsies, durometry correlated better with skin thickness than mRSS. Durometry may be considered as an alternative method to quantify skin involvement in patients with diffuse SSc. The strong inter-rater agreement suggests that the method may be useful for the assessment of patients by multiple researchers, as in clinical trials.
机译:由于调查员相关的主观性,改良Rodnan的皮肤分数(MRSS)的再现性和可靠性是争论。在这里,我们评估硬度是否与弥漫性全身硬化症(SSC)的患者的MRS相关。这项横断面研究于2018年12月至2019年6月进行,其中58例弥漫性SSC患者。两位认证的研究人员对彼此盲目的分数进行了迈尔斯,然后在17个预定义的皮肤场所进行了硬度。对于Duromry和MRSS,每种皮肤部位的个体评分都已注册。比较了每个研究人员测量的杜何和司机结果,以及来自不同研究人员的分数。从患者的子集中提供前臂皮肤活组织检查的皮肤厚度测量,以进行比较。统计分析包括Cohen的Kappa系数,脑内相关系数,Kendall的系数和Spearman的测试。平均(标准偏差,SD)患者年龄为44.8(12.9)岁,女性是88%。根据特定评估的位点,帧间间协议从0.88〜0.99(腹积相关系数)(腹部相关系数)为杜氏多术的0.54至0.79(Cohen的Kappa系数)。当将数据与在前臂活组织检查中评估的皮肤厚度进行比较时,硬质术与皮肤厚度更好地相关,而不是MRSS。硬质抑制可以被认为是量化弥漫性SSC患者的皮肤患者的替代方法。强劲的评估间协定表明该方法可用于评估多个研究人员,如临床试验中的患者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号